ISRG vs. PFE

In the year-to-date period, ISRG achieves a 3.24% return, which is significantly higher than PFE's -0.45% return. Over the past 10 years, ISRG has outperformed PFE with an annualized return of 24.84%, while PFE has yielded a comparatively lower 2.35% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Intuitive Surgical, Inc. (ISRG) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ISRG Sharpe Ratio is 1.97, which is higher than the PFE Sharpe Ratio of -0.06. The chart below compares the historical Sharpe Ratios of ISRG and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

ISRG has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.36%.

The maximum ISRG drawdown since its inception was -82.25%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for ISRG and PFE. For additional features, visit the drawdowns tool.

Intuitive Surgical, Inc. (ISRG) and Pfizer Inc. (PFE) have volatilities of 6.41% and 6.54%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Intuitive Surgical, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.